I am a...
Seeking more information about spasticity? The Spasticity Alliance is here to help.
The MILESTONESM Stroke Study is looking at the safety and effectiveness of an investigational medication for the treatment of walking difficulties in people who have had an ischemic stroke at least 6 months ago.
Why is this study important?
Currently, there are no FDA approved medications available for improving the walking problems in these patients. Physical therapy and rehabilitation are the current mainstays of treatment to assist with walking problems following a stroke. Pharmaceutical companies use medical research studies such as the MILESTONESM Stroke Study to learn more about unapproved medications before they are made available to the public. By taking part in this study, you will be making a contribution to stroke therapy research.
What are the challenges related to this study?
The investigational medication has been approved as a treatment to improve walking problems associated with a different disease, however not in patients recovering from a stroke. This use is still investigational. The investigational medication is being tested in people who have had an ischemic stroke, because this condition has some nervous system changes that may be similar to what is seen in the disease for which this medication is approved. In an earlier study with about 80 participants who have had a stroke, there was some initial evidence of improvement in walking while taking the investigational medication twice a day for 2 weeks, when compared with a placebo.
Who is eligible to participate in this study?
TO PRE-QUALIFY FOR THIS STUDY, YOU MUST:
YOU MUST NOT:
All study-related visits, assessments, and study medication will be provided to participants at no cost. In addition, compensation for time and travel may be provided.
Take part in the Phase 3 clinical study for people with walking problems at least 6 months after an ischemic stroke
The content of this webpage does not imply National Stroke Association's endorsement of any product, treatment, service or entity. National Stroke Association strongly recommends that you consult with a healthcare professional about diagnosis and treatment before participating in a clinical trial. National Stroke Association has no affiliation with any specific clinical trials.
For over 30 years we have been the trusted source for free resources and education to the stroke community. Together, we empower survivors and their circle of care to thrive after stroke. Make your tax-deductible donation today to support the growing needs of the stroke community.